Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigious | ||
Readability |
H.S. freshman Avg
|
New words:
acquisition, Additionally, adequacy, adequate, adult, Alexion, alliance, allocation, approved, assessment, average, biotechnology, Bulletin, chemotherapy, comply, consideration, consulting, decision, degradation, deliver, enable, enterprise, exceeded, FDA, February, FIN, Food, forgoing, forma, Genentech, GMP, Good, guidance, Immunoglobulin, inflammation, integrated, Interpretation, irritation, kidney, lead, located, magnitude, maintenance, maker, manufacturing, mapping, medical, mouth, mucosal, nephropathy, objective, ongoing, onset, oral, outlook, party, pathway, Pfizer, pharmacogenomic, pro, prominent, purpose, quantitative, radiotherapy, regulatory, renal, royalty, run, Screen, segment, sell, shifting, side, slight, supervision, tabular, team, throat, trial, unable, unavailable, understanding, undertaken, unique, unmet, Variable, voluntarily, xiii
Filing tables
Filing exhibits
CRGN similar filings
Filing view
External links